The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck

Diagnostic Cytopathology

Volumn 42, Issue 1, 2014, Pages 85-93

  Holmes, Brittany J ^a   Westra, William H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

branchial cleft cyst; cell block; cystic squamous cell carcinoma; fine needle aspiration (FNA); human papillomavirus; hybrid capture 2; in situ hybridization; p16 immunohistochemistry

Indexed keywords

PEROXIDASE;

CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SURGERY; CELL STRUCTURE; CYTOPATHOLOGY; FINE NEEDLE ASPIRATION BIOPSY; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MORPHOMETRICS; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

BRANCHIAL CLEFT CYST; CELL BLOCK; CYSTIC SQUAMOUS CELL CARCINOMA; FINE NEEDLE ASPIRATION (FNA); HUMAN PAPILLOMAVIRUS; HYBRID CAPTURE 2; IN SITU HYBRIDIZATION; P16 IMMUNOHISTOCHEMISTRY;

BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS;

EID: 84891416909     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.23014     Document Type: Review

References (52)

1. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-4301.
2. Pai SI, Westra WH,. Molecular pathology of head and neck cancer: Implications for diagnosis, prognosis, and treatment. Annu Rev Pathol 2009; 4: 49-70.
3. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-420.
4. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956.
5. Smith EM, Ritchie JM, Summersgill KF, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108: 766-772.
6. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
7. Begum S, Cao D, Gillison M, et al. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005; 11: 5694-5699.
8. Singhi AD, Westra WH,. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010; 116: 2166-2173.
9. Strati K, Lambert PF,. Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer. Cancer Res 2007; 67: 11585-11593.
10. El-Naggar AK, Westra WH,. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: A guide for interpretative relevance and consistency. Head Neck 2012; 34: 459-461.
11. Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 747.
12. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
13. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
14. Wu A, Zeng Q, Kang TH, et al. Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer. Gene Ther 2011; 18: 304-312.
15. Chernock RD, El-Mofty SK, Thorstad WL, et al. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: Utility of microscopic features in predicting patient outcome. Head Neck Pathol 2009; 3: 186-194.
16. Westra WH,. The changing face of head and neck cancer in the 21st century: The impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 2009; 3: 78-81.
17. Singhi AD, Stelow EB, Mills SE, et al. Lymphoepithelial-like carcinoma of the oropharynx: A morphologic variant of HPV-related head and neck carcinoma. Am J Surg Pathol 2010; 34: 800-805.
18. Begum S, Westra WH,. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol 2008; 32: 1044-1050.
19. Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: Frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol 2009; 33: 1720-1724.
20. Masand RP, El-Mofty SK, Ma XJ, et al. Adenosquamous carcinoma of the head and neck: Relationship to human papillomavirus and review of the literature. Head Neck Pathol 2011; 5: 108-116.
21. Carpenter DH, El-Mofty SK, Lewis JS, Jr,. Undifferentiated carcinoma of the oropharynx: A human papillomavirus-associated tumor with a favorable prognosis. Mod Pathol 2011; 24: 1306-1312.
22. Bishop JA, Westra WH,. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol 2011; 35: 1679-1684.
23. Kraft S, Faquin WC, Krane JF,. HPV-associated neuroendocrine carcinoma of the oropharynx: A rare new entity with potentially aggressive clinical behavior. Am J Surg Pathol 2012; 36: 321-330.
24. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck 2008; 30: 898-903.
25. Jarboe EA, Hunt JP, Layfield LJ,. Cytomorphologic diagnosis and HPV testing of metastatic and primary oropharyngeal squamous cell carcinomas: A review and summary of the literature. Diagn Cytopathol 2012; 40: 491-497.
26. Umudum H, Rezanko T, Dag F, et al. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas. Cancer 2005; 105: 171-177.
27. Zhao M, Rosenbaum E, Carvalho AL, et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer 2005; 117: 605-610.
28. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-Associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747.
29. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: Response and survival positively associated with HPV16 copy number. J Clin Oncol 2008; 26: 3138-3146.
30. Agrawal Y, Koch WM, Xiao W, et al. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin Cancer Res 2008; 14: 7143-7150.
31. Begum S, Gillison ML, Ansari-Lari MA, et al. Detection of human papillomavirus in cervical lymph nodes: A highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003; 9: 6469-6475.
32. Begum S, Gillison ML, Nicol TL, et al. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2007; 13: 1186-1191.
33. El-Mofty SK, Zhang MQ, Davila RM,. Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: A reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol 2008; 2: 163-168.
34. Bishop JA, Ogawa T, Chang X, et al. HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol 2012; 36: 142-148.
35. Weichert W, Schewe C, Denkert C, et al. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung. Am J Surg Pathol 2009; 33: 513-520.
36. Cao D, Begum S, Ali SZ, et al. Expression of p16 in benign and malignant cystic squamous lesions of the neck. Hum Pathol 2010; 41: 535-539.
37. Robinson M, Sloan P, Shaw R,. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol 2010; 46: 492-496.
38. Lewis JS, Jr,. p16 immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 2012; 6 (Suppl 1): S75-S82.
39. Schlecht NF, Brandwein-Gensler M, Nuovo GJ, et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol 2011; 24: 1295-1305.
40. Jordan RC, Lingen MW, Perez-Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol 2012; 36: 945-954.
41. Ukpo OC, Flanagan JJ, Ma XJ, et al. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol 2011; 35: 1343-1350.
42. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-2472.
43. Lewis JS, Jr, Thorstad WL, Chernock RD, et al. p16 positive oropharyngeal squamous cell carcinoma: An entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 2010; 34: 1088-1096.
44. Weinberger PM, Yu Z, Haffty BG, et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res 2004; 10: 5684-5691.
45. Grimes R, Garcia-Buitrago MT, Jorda M, et al. p16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma. Acta Cytol 2012; 57: 33-37.
46. Jannapureddy S, Cohen C, Lau S, et al. Assessing for primary oropharyngeal or nasopharyngeal squamous cell carcinoma from fine needle aspiration of cervical lymph node metastases. Diagn Cytopathol 2010; 38: 795-800.
47. Zhang MQ, El-Mofty SK, Davila RM,. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: A tool for identifying the site of an occult head and neck primary. Cancer 2008; 114: 118-123.
48. Bishop JA, Maleki Z, Valsamakis A, et al. Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: A convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol 2012; 120: 18-25.
49. Solomides CC, Bibbo M, Wang ZX,. Assessment of fine needle aspiration specimen adequacy for high-risk HPV detection and genotyping in oropharyngeal squamous cell carcinoma. Acta Cytol 2012; 56: 196-198.
50. Boland JM, McPhail ED, Garcia JJ, et al. Detection of human papilloma virus and p16 expression in high-grade adenoid cystic carcinoma of the head and neck. Mod Pathol 2012; 25: 529-536.
51. Lin YC, Chen KC, Lin CH, et al. Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas. Int J Oral Maxillofac Surg 2012; 41: 354-360.
52. Jarboe EA, Willis M, Bentz B, et al. Detection of human papillomavirus using hybrid capture 2 in oral brushings from patients with oropharyngeal squamous cell carcinoma. Am J Clin Pathol 2011; 135: 766-769.